NCT05826600 2026-04-24A Study of OMX-0407 in Patients With Previously Treated Solid Tumours That Can't be Removed SurgicallyiOmx Therapeutics AGPhase 1/2 Terminated68 enrolled
NCT03860272 2026-03-30Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced CancerAgenus Inc.Phase 1 Active not recruiting499 enrolled